Altria Group Inc. Chief Executive Marty Barrington is retiring and will be replaced by another 25-year company veteran. Mr. Barrington, who has held the top post for six years, will retire in May after a quarter of a century with the tobacco company, Altria said Thursday. His replacement is Howard Willard, 54, the company's current operating chief and former finance chief.
ApidraÂ® (insulin glulisine) is a prescription form of insulin used to treat type 1 diabetes and type 2 diabetes in adults. It is a rapid-acting insulin used to help control the spike in blood sugar levels that occurs after meals. It is typically used in combination with a long-acting insulin.
Glipizide is used along with diet and exercise, and sometimes with other medications, to treat type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in the blood).